» Articles » PMID: 34630944

Transcriptional and Translational Landscape of in Response to Caspofungin

Abstract

has emerged as a serious worldwide threat by causing opportunistic infections that are frequently resistant to one or more conventional antifungal medications resulting in high mortality rates. Against this backdrop, health warnings around the world have focused efforts on understanding fungal biology and effective prevention and treatment approaches to combat this fungus. To date, there is little information about the differentially expressed genes when this fungus is treated with conventional antifungals, and caspofungin is a standard echinocandin deployed in the therapy against . In this work, we treated two distinct strains of for 24 h with caspofungin, and the cellular responses were evaluated at the morphological, translational and transcriptional levels. We first observed that the echinocandin caused morphological alterations, aggregation of yeast cells, and modifications in the cell wall composition of . Transcriptomic analysis revealed an upregulation of genes related to the synthesis of the cell wall, ribosome, and cell cycle after exposure to caspofungin. Supporting these findings, the integrated proteomic analysis showed that caspofungin-treated cells were enriched in ribosome-related proteins and cell wall, especially mannoproteins. Altogether, these results provide further insights into the biology of and expands our understanding regarding the antifungal activity of caspofungin and reveal cellular targets, as the mannose metabolism, that can be further explored for the development of novel antifungals.

Citing Articles

Evolutionary accumulation of 1 mutations from clinical echinocandin-resistant .

Tian S, Wu Y, Li H, Rong C, Wu N, Chu Y Emerg Microbes Infect. 2024; 13(1):2377584.

PMID: 38989545 PMC: 11265302. DOI: 10.1080/22221751.2024.2377584.


The Potential of Dutasteride for Treating Multidrug-Resistant Infection.

Borgio J, Almandil N, Selvaraj P, John J, Alquwaie R, AlHasani E Pharmaceutics. 2024; 16(6).

PMID: 38931930 PMC: 11207579. DOI: 10.3390/pharmaceutics16060810.


Rapid evolution of an adaptive multicellular morphology of Candida auris during systemic infection.

Bing J, Guan Z, Zheng T, Ennis C, Nobile C, Chen C Nat Commun. 2024; 15(1):2381.

PMID: 38493178 PMC: 10944540. DOI: 10.1038/s41467-024-46786-8.


Candida auris undergoes adhesin-dependent and -independent cellular aggregation.

Pelletier C, Shaw S, Alsayegh S, Brown A, Lorenz A PLoS Pathog. 2024; 20(3):e1012076.

PMID: 38466738 PMC: 10957086. DOI: 10.1371/journal.ppat.1012076.


The many faces of Candida auris: Phenotypic and strain variation in an emerging pathogen.

Santana D, Zhao G, OMeara T PLoS Pathog. 2024; 20(3):e1012011.

PMID: 38427609 PMC: 10906884. DOI: 10.1371/journal.ppat.1012011.


References
1.
Thak E, Lee S, Xu-Vanpala S, Lee D, Chung S, Bahn Y . Core -Glycan Structures Are Critical for the Pathogenicity of Cryptococcus neoformans by Modulating Host Cell Death. mBio. 2020; 11(3). PMC: 7218283. DOI: 10.1128/mBio.00711-20. View

2.
Caplan T, Polvi E, Xie J, Buckhalter S, Leach M, Robbins N . Functional Genomic Screening Reveals Core Modulators of Echinocandin Stress Responses in Candida albicans. Cell Rep. 2018; 23(8):2292-2298. DOI: 10.1016/j.celrep.2018.04.084. View

3.
Seneviratne C, Wang Y, Jin L, Abiko Y, Samaranayake L . Proteomics of drug resistance in Candida glabrata biofilms. Proteomics. 2010; 10(7):1444-54. DOI: 10.1002/pmic.200900611. View

4.
Lara-Aguilar V, Rueda C, Garcia-Barbazan I, Varona S, Monzon S, Jimenez P . Adaptation of the emerging pathogenic yeast to high caspofungin concentrations correlates with cell wall changes. Virulence. 2021; 12(1):1400-1417. PMC: 8244764. DOI: 10.1080/21505594.2021.1927609. View

5.
Nailis H, Kucharikova S, Ricicova M, Van Dijck P, Deforce D, Nelis H . Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression. BMC Microbiol. 2010; 10:114. PMC: 2862034. DOI: 10.1186/1471-2180-10-114. View